Inventor · disambiguated record
Nisha Palackal
Also filed as: PALACKAL NISHA
17 granted patents·8 pending applications·73 citations·filing 2009–2024
94Inventor score
Top patents by PatentIndex Score
25 records- 0198US11459373B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Oct 4, 2022·8 cites·16 claims
- 0298US11459374B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Oct 4, 2022·13 cites·26 claims
- 0398US11299532B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Apr 12, 2022·8 cites·22 claims
- 0498US11174283B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Nov 16, 2021·13 cites·12 claims
- 0598US11053280B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Jul 6, 2021·19 cites·11 claims
- 0697US12049489B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Jul 30, 2024·2 cites·30 claims
- 0797US11649273B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted May 16, 2023·2 cites·28 claims
- 0897US11407813B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Aug 9, 2022·3 cites·20 claims
- 0994US12202883B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Granted Jan 21, 2025·0 cites·12 claims
- 1094US11505594B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Nov 22, 2022·1 cites·27 claims
- 1194US11180540B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Nov 23, 2021·2 cites·28 claims
- 1294US2025197474A1Anti-vegf protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1391US11286290B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Mar 29, 2022·1 cites·30 claims
- 1490US12077570B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Sep 3, 2024·0 cites·30 claims
- 1588US11098112B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Aug 24, 2021·1 cites·26 claims
- 1687US12054533B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Aug 6, 2024·0 cites·18 claims
- 1778US2025206803A1Methods of characterizing and purifying vegf receptor fusion proteinREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1872US2023417701A1Ce-western applications for antibody developmentREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1967US11782023B2Ce-western applications for antibody developmentREGENERON PHARMA·Filed 2019·Granted Oct 10, 2023·0 cites·18 claims
- 2067US2024385188A1Labeling and anti-drug antibody assays for aav vectorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 2165US2025002992A1Methods of analyzing and characterizing polyadenylation on messenger ribonucleic acidREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 2264US2025208103A1COMPREHENSIVE ANALYTICAL CHARACTERIZATION OF mRNA UNDER ONE OR MORE STRESS CONDITIONSREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 2358US2023296559A1Methods and systems for analyzing polypeptide variantsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2450US2020393455A1Methods for identifying and quantitating host cell proteinREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 2547US8440417B2Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin D synthasePALACKAL NISHA·Filed 2009·Granted May 14, 2013·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Nisha Palackal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →